The session will examine a wide range of innovative therapeutic targets, including proteins, signaling pathways, and cellular processes that play a crucial role in the pathology of Alzheimer's disease. Experts will present their pioneering research on addressing neuroinflammation, synaptic dysfunction, and neuroprotective mechanisms, providing new perspectives on potential treatment approaches.
A key emphasis of the session will be on unraveling the underlying mechanisms of action of these novel therapeutic targets, enhancing our understanding of how these strategies can effectively combat Alzheimer's disease. Researchers will share their insights into the molecular and cellular processes contributing to disease progression, underscoring the potential of these novel approaches to arrest or even reverse the neurodegenerative processes associated with Alzheimer's.
The forthcoming Alzheimer's 2024 conference will feature a dedicated scientific session exploring the latest advancements in this field, showcasing promising therapeutic strategies that challenge traditional approaches and hold the potential to transform Alzheimer's care.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
